1.Frontiers in pharmacologyDisruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma."11-4724 was used in Immunocytochemistry to indicate the enhanced anti-tumor efficacy of PD-1-deficient chimeric antigen receptor T cells against hepatocellular carcinoma."AuthorsGuo X,Jiang H,Shi B,Zhou M,Zhang H,Shi Z,Du G,Luo H,Wu X,Wang Y,Sun R,Li Z2.Frontiers in pharmacologyDisruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma."11-4724 was used in Immunocytochemistry to indicate the enhanced anti-tumor efficacy of PD-1-deficient chimeric antigen receptor T cells against hepatocellular carcinoma."AuthorsGuo X,Jiang H,Shi B,Zhou M,Zhang H,Shi Z,Du G,Luo H,Wu X,Wang Y,Sun R,Li Z3.Experimental and therapeutic medicineProteomic changes of CD4+/CD25+/forkhead box p3+regulatory T cells in a 30-day rat model of sepsis survival."11-4724 was used in Flow cytometry/Cell sorting to explain the mechanism by which regulatory T-cells (Tregs) naturally recover and indicate that Tregs in the blood and spleen vary."AuthorsJiao Y,Tan S,Xiong J4.Journal of veterinary scienceExtensive characterization of feline intra-abdominal adipose-derived mesenchymal stem cells."11-4724 was used in Flow cytometry/Cell sorting to demonstrate that fully characterized fAD-MSCs could be beneficial when considering the use of these cells in feline disease research."AuthorsKim HR,Lee J,Byeon JS,Gu NY,Lee J,Cho IS,Cha SH5.Iranian journal of basic medical sciencesSertoli cell condition medium can induce germ like cells from bone marrow derived mesenchymal stem cells."11-4724 was used in Flow cytometry/Cell sorting to confirm that effect Sertoli cell condition medium, can differentiate germ cells into bone marrow mesenchymal stem cells."AuthorsMonfared MH,Minaee B,Rastegar T,Khrazinejad E,Barbarestani M |